MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One of several biosimilar value drivers for SandozSandoz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback